ASCO 2015: Latest in chronic lymphocytic leukaemia

Subgroup analysis of molecular markers in phase III study of high risk low-grade glioma

Advanced DNA sequencing test used to match rare cancers

Raloxifene retained approximately 81% of the effectiveness of tamoxifen in preventing invasive breast cancer

Next generation inhibitors help overcome problems of resistance in ALK positive lung cancer

Transarterial chemoembolization with or without sorafenib for intermediate-stage hepatocellular carcinoma

Ibrutinib combination regimen shows substantial benefits in relapsed CLL

Eribulin extends overall survival for patients with advanced liposarcoma and leiomyosarcoma

Immunotherapy developments in lung, head and neck, liver and PD-1 repsonse prediction

Pembrolizumab for head and neck cancer

Genomic marker predicts anti-PD-1 response in several cancers

Pembrolizumab shows promising activity against head and neck cancer